Viewpoint: CRISPR gene editing might quell ‘frankenfood’ fears and win consumer support for biotech

GetStoredImage
Credit: Brent Warren, Kurt Lawton (Corn) Getty Images (DNA rendering)

The debate surrounding genetically engineered (“GE” or “GMO”) plants and animals has historically been, and still is, extremely divisive. Anti-GMO activists raise many objections, including two that often resonate with a segment of the public: (1) control of the food supply by a few multinational corporations, and (2) reliance on pesticides.

…

But what if modern biotechnology could take those two objections out of the debate, as well as directly benefit consumers? Would there be greater consumer acceptance? A new generation of agricultural products that are being created through gene-editing techniques, such as CRISPR and TALENS, certainly have the potential to accomplish that.

Gene editing is cheaper and easier to use than genetic engineering, so academic scientists and new startup biotechnology companies, in addition to multinational corporations, have begun to use these technologies to make new varieties of crops and animals with useful traits. Many gene-edited products in the commercial pipeline are not linked to pesticides and have unique traits that could be of interest to consumers.

…

If they get to market and consumers recognize the benefits they provide, then gene-edited crops and animals could be the spark to bridge the divide in the GMO debate.

Read full, original article: Gene-Edited Plants and Animals: Can They Bridge the Divide in the GMO Debate?

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.